A Phase I/II Randomized Double-Blind Placebo-Controlled Trial of Cannabidiol for chronic radiculopathic pain syndromes maintained on chronic opioid therapy

Brief description of study

The purpose of this research study is to see how safe and effective Cannabidiol (CBD) is for the treatment of chronic non-cancer spinal radiculopathic pain conditions in people maintained on an ongoing dose of opioid pain medications. The researchers will assess the effects of CBD on opioid medication use, pain as well as aspects of thinking, emotions and behavior.

Clinical Study Identifier: s21-00230
ClinicalTrials.gov Identifier: NCT04760613
Principal Investigator: Stephen Ross.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.